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Relationship between Adiponectin and different clinical types of
Coronary heart disease
Hongjun Liu
Huanyuan County The second people Hospital
OBJECTIVES Cathepsin L (CATL) is a kind of papain family of ho-
mocysteine proteolytic enzymes in the form of enzymes, and stored in
the lysosome, It can produce the risk of cardiovascular diseases in
human, which of the mechanism is not fully established. Higher CATL
concentration is associate of cardiovascular events. So, for the past
few years, scholars pay more attention to the factor. There is not
plenty of studies in China, however, in west countries, there are
adequate evidences from animal and human studies. But the role of
CATL in coronary heart disease remains to be established and need
further more researches to conﬁrm.
METHODS Coronary angiography (CAG) was performed in 64 hospitalized
patients suspected as having coronary heart disease(CHD). Patients who
were conﬁrmedwith CHDwere internalized toCHDgroup(n¼64); andnon-
CHD group as control group(n¼26). The CHD group were further divided
into 3 subgroups, they are:stable angina pectoris(SAP, n¼27); unstable
angina pectoris(UAP, n¼23) and acute myocardial infarction(AMI, n¼14).
Enzyme linked immunosorbent assay were made use of to detect the mass
of CATL and the concentration of hs-CRP. The corresponding data was
analyzed by SPSS 17.0 software.
RESULTS (1) Plasma CATL concentration in CHD group are higher
than in the control group(4543.161444.29 vs 1654.16154.16ng/mL,
P<0.05);plasma CATL mass in SAP were higher than in control
group(2942.74280.62 vs 1654.16154.16 ng/mL, P<0.05); Plasma
CATL mass in UAP were higher than SAP group (5479.38485.60 vs
2942.74280.62 ng/mL, P<0.05); plasma CATL mass in AMI were
higher than in UAP group(6091.70315.52 vs 5479.38485.60ng/mL,
P<0.05); Plasma hs-CRP concentration in SAP group are higher than
control group (1.440.29 vs 0.380.22 mg/L, P<0.05); Plasma hs-CRP
mass in UAP group are also higher than SAP group (4.160.54 vs
1.440.29 mg/L, P<0.05) Plasma hs-CRP mass in AMI group are also
higher than UAP group (6.000.90 vs 4.160.54mg/L, P<0.05) (2)
CATL was closely related in Gensini score(r¼0.39, P<0.05). (3) Plasma
CATL concentration was Positively correlated with TC, TG, and non-
correlated with high blood pressure. Hs-CRP was not an independent
risk factor for coronary heart disease, but CATL had an independent
relationship with coronary heart disease.
CONCLUSIONS 1. Relation of plasma CATL concentration to the sub-
groups of CHD: CATL density were gradually increase from SAP, UAP
to AMI; The trend may mention that CATL may be a productive factor.
2. Relation of plasma hs-CRP concentration to CHD: the subgroups of
CHD group, hs-CRP density were gradually increase from SAP, UAP to
AMI; The trend may mention that CATL may be a damage factor. 3.
There were positive correlation between plasma CATL concentration
and plasma hs-CRP concentration.
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A cohort study of early cardiologist consultation by telemedicine on the
critical Non-STEMI inpatients
Wisit Wichitkosoom, Suwanna Nathee
Cardiac Center, Udonthani General Hospital
OBJECTIVES To ﬁnd out the more effect of early cardiologist
consultation using a simple technology on the diagnosis and early
proper management of patients with Non-STEMI at emergency
department of district hospitals without cardiologist on site before
transferred.
METHODS A cohort study was performed in Udonthani general hos-
pital at Udonthani province. From 1 October 2012 – 30 September 2013
with 892 patients diagnosed with Non-STEMI. All patients mean aged
46.8 years of age who had been transferred because of Non-STEMI
diagnosed, over a 12 week period of studied. Patients whose trans-
ferred, in addition to receiving proper care, were offered a cardiologist
consultation with average time to Udonthani hospital 1.5 hour. The
main outcome measure was length of hospital stay, mortality at 3
months, inpatient investigation, and transfer rate to the higher facil-
itated hospital were also studied.
RESULTS Hospital stay was signiﬁcantly shorter for those didn’t
consult cardiologist (hazard ratio 1.19; approximate 95% CI 1.001 to
1.251; p ¼ 0.039). The 136 cases were transferred to higher facilitated
hospital. No statistically signiﬁcant in overall mortality between the
groups (p¼0.068).CONCLUSIONS Early cardiologist consultant can reduce length of
hospital stay for patients with cardiovascular conditions outside of
cardiac center. The new basic technology can apply for the safety
patient.GW26-e3602
Effect of different intervening models in improving medication adherence
of ACS patients : Results from the Bridging the Gap on CHD Secondary
Prevention in China (BRIG) project
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Diseases
OBJECTIVES Medication of four evidence-based drugs, including
anti-platelet agent, statins, b-blockers and angiotensin converting
enzyme (ACE) inhibitor can effectively improve the prognosis of pa-
tients with acute coronary syndrome (ACS). The study aims to eval-
uate the outcome of the intervening measures (the handout of the
promotional materials and/or publicity and education about second-
ary prevention from nurses) for hospitalized ACS patients in
improving post-discharge medication adherence of ACS patients.
METHODS Thirty-four hospitals from 21 provinces in China partici-
pated in this study. All the hospitals were randomly divided into four
groups: one control group (Group 1) who received routine care and
three intervention groups. Group 2 was provided with the promo-
tional materials, and Group 3 got the publicity and education about
secondary prevention from nurses, and Group 4 received the com-
bined intervention measures of Groups 2 and 3. The ACS patients of
three intervention groups were interfered in hospitalization. All the
ACS patients were followed up for 6 months after discharge.
RESULTS Two thousand two hundred and forty-four patients were
included for analysis after the four groups went through Propensity
Score.
1) Among the use of four evidence-based medicines for secondary
prevention, the administration rates of anti-platelet, statins, ACEI/
ARB and the combination of the four medicines were 98.3w94.9%,
93.0w88.6%, 60% and 45.9%, respectively.
2) The follow-up of ACS patients conducted at 6 months after
discharge displayed that, the medicine adherence rates in Groups 3
and 4 were higher than that in Group 1 and the differences were sta-
tistically signiﬁcant.
A multiple-factor analysis indicated that the combined intervention
group had the highest medicine adherence rate, and the administra-
tion rate of the combination of the four medicines was 19% higher
than that of the control group (P<0.05). 3) Control rate of LDL-
C <100mg/dl at six months after discharge was the highest (69.6%) in
the combined intervention group. Control rates of blood
pressure <140/90mmHg in Groups 3 and 4 were higher than that in
Group 1, and had statistical differences.
CONCLUSIONS Combined intervening measures of the handout of
promotional materials and the publicity and education about sec-
ondary prevention from nurses during hospitalization can improve
post-discharge medication adherence of ACS patients. Combined
intervention plays a better effect compared with the handout of pro-
motional materials or the publicity and education about secondary
prevention from nurses alone. This method is simple and easy to
perform and would give a positive reference to the medication
adherence for secondary prevention drugs of the current coronary
heart disease in China.GW26-e0189
Intra-aortic balloon pump is irrelevant to the short and long term mortality
rate of patients with acute myocardial infarction
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OBJECTIVES Intra-aortic balloon pump (IABP) has been extensively
used in clinical practice as a circulatory-assist device. However, the
efﬁcacy of IABP has been doubted since its ﬁrst application during
the early 1960s. Current literature demonstrates wide inconsistency of
the indications for IABP utilization and outcomes. The aim of our
current updated meta-analysis was to assess the potential beneﬁts of
